These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37848395)

  • 1. Effectiveness of blood steroidal passport markers for detecting testosterone abuse in Asians.
    Okano M; Shiomura S
    Drug Test Anal; 2024 Jun; 16(6):595-603. PubMed ID: 37848395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
    Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
    Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant genotyping results using DNA isolated from anti-doping control urine samples.
    Choong E; Schulze JJ; Ericsson M; Rane A; Ekström L
    Drug Test Anal; 2017 Jul; 9(7):994-1000. PubMed ID: 27706926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse.
    Okano M; Ueda T; Nishitani Y; Kano H; Ikekita A; Kageyama S
    Drug Test Anal; 2013 Mar; 5(3):166-81. PubMed ID: 22887913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid profiles of professional soccer players: an international comparative study.
    Strahm E; Sottas PE; Schweizer C; Saugy M; Dvorak J; Saudan C
    Br J Sports Med; 2009 Dec; 43(14):1126-30. PubMed ID: 19282302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Profiling of Endogenous Steroids in Blood Using the Athlete Biological Passport Approach.
    Equey T; Salamin O; Ponzetto F; Nicoli R; Kuuranne T; Saugy J; Saugy M; Aikin R; Baume N
    J Clin Endocrinol Metab; 2023 Jul; 108(8):1937-1946. PubMed ID: 36794909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports.
    Ponzetto F; Mehl F; Boccard J; Baume N; Rudaz S; Saugy M; Nicoli R
    Anal Bioanal Chem; 2016 Jan; 408(3):705-19. PubMed ID: 26677027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of multivariate statistics to the Steroidal Module of the Athlete Biological Passport: A proof of concept study.
    Alladio E; Caruso R; Gerace E; Amante E; Salomone A; Vincenti M
    Anal Chim Acta; 2016 May; 922():19-29. PubMed ID: 27154828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.
    Anielski P; Simmchen J; Wassill L; Ganghofner D; Thieme D
    Drug Test Anal; 2011 Oct; 3(10):645-51. PubMed ID: 21928278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of multiple human chorionic gonadotropin administrations on serum and urinary steroid Athlete Biological Passport profiles in males.
    Goodrum JM; Moore C; Crouch AK; Eichner D; Miller GD
    Drug Test Anal; 2023; 15(11-12):1371-1381. PubMed ID: 37749856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the UGT2B17 polymorphism on the steroid profile. Results of a crossover clinical trial in athletes submitted to testosterone administration.
    Martín-Escudero P; Muñoz-Guerra JA; García-Tenorio SV; Garde ES; Soldevilla-Navarro AB; Galindo-Canales M; Prado N; Fuentes-Ferrer ME; Fernández-Pérez C
    Steroids; 2019 Jan; 141():104-113. PubMed ID: 30503386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of combined ((ES/EG)/(TS/TG)) ratio as a marker of testosterone intake in men.
    Schulze J; Pettersson-Bohlin K; Thörngren JO; Ekström L
    Drug Test Anal; 2021 Aug; 13(8):1576-1579. PubMed ID: 33864421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
    Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
    Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes.
    Ekström L; Cevenini L; Michelini E; Schulze J; Thörngren JO; Belanger A; Guillemette C; Garle M; Roda A; Rane A
    Eur J Clin Invest; 2013 Mar; 43(3):248-55. PubMed ID: 23294483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Codeine influences the serum and urinary profile of endogenous androgens but does not interact with the excretion rate of administered testosterone.
    Lehtihet M; Andersson A; Börjesson A; Schulze J; Rane A; Ericsson M; Ekström L
    Drug Test Anal; 2018 Apr; 10(4):723-730. PubMed ID: 28901724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
    Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of doping biomarkers after administration of a single dose testosterone gel.
    Mullen J; Börjesson A; Hopcraft O; Schulze JJ; Ericsson M; Rane A; Lehtihet M; Ekström L
    Drug Test Anal; 2018 May; 10(5):839-848. PubMed ID: 29150907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes.
    Ponzetto F; Parasiliti-Caprino M; Gesmundo I; Marinelli L; Nonnato A; Nicoli R; Kuuranne T; Mengozzi G; Ghigo E; Settanni F
    Talanta; 2023 Apr; 255():124218. PubMed ID: 36603442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.
    Deshmukh N; Petróczi A; Barker J; Székely AD; Hussain I; Naughton DP
    Subst Abuse Treat Prev Policy; 2010 Apr; 5():7. PubMed ID: 20429943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-individual variation of the urinary steroid profiles in Swedish and Norwegian athletes.
    Mullen J; Baekken LV; Törmäkangas T; Ekström L; Ericsson M; Hullstein IR; Schulze JJ
    Drug Test Anal; 2020 Jun; 12(6):720-730. PubMed ID: 32052600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.